Although more than half of U.S. pharmacy schools offering some education on end-of-life care, more needs to be done to train future R.Ph.s, according to a Texas Tech study.
How Differences in Bispecific Therapies Impact Myeloma Treatment Operations
April 18th 2024According to Kirollos Hanna, PharmD, although similarities exist between bispecific therapies in the myeloma space, health care providers should take special note of practical differences and nuances associated with each when operationalizing them at their site of care.